Search Results - "Straubhar, Alli M."

Margin status in vulvovaginal melanoma: Management and oncologic outcomes of 50 cases by Straubhar, Alli M., Chan, May P., Uppal, Shitanshu

“…•The 5-year overall survival for vulvovaginal melanoma is 60%.•The 5-year local progression free survival for vulvovaginal melanoma is 63%.•Preinvasive disease…”
Get full text

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma by Stenehjem, David D., Agarwal, Neeraj, Liu, Ting, Hawatmeh, Jamil S., Patel, Shiven B., Poole, Austin, Ravulapati, Sowmya, Agarwal, Archana M., Albertson, Daniel, Tantravahi, Srinivas K., Straubhar, Alli M.

“…Metastatic renal cell carcinoma with sarcomatoid histology (SmRCC) is associated with poor survival. No data is available from randomized trials on the…”
Get full text

Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer by McLaughlin, Hannah D, Greco, Patricia, Straubhar, Alli M, Rolston, Aimee, McCool, Kevin, Brackmann, Melissa, Siedel, Jean H, McLean, Karen, Reynolds, R Kevin, Uppal, Shitanshu

“…To compare the venous thromboembolism (VTE) rate in patients with ovarian cancer undergoing neoadjuvant chemotherapy before and after implementing routine…”
Get full text

Refusal of surgery and survival outcomes in endometrial cancer by Straubhar, Alli M, Parsons, Matthew W, Francis, Samual, Gaffney, David, Maurer, Kathryn A

“…The goal of this study was to determine the impact refusal of surgery has on overall survival in patients with endometrial cancer. From January 2004 to…”
Get more information

Cross-sectional survey of surgical practices among gynecologic oncologists in the United States by Straubhar, Alli M., Zhou, Qin, Iasonos, Alexia, Clarke-Pearson, Daniel L., Cliby, William A., Hoffman, Mitchel S., Chi, Dennis S.

“…We sought to document current surgical practices among gynecologic oncologists in the United States. In March/April 2020, we conducted a cross-sectional survey…”
Get full text

Provider compliance with a tailored opioid prescribing calculator in gynecologic surgery by Straubhar, Alli M., Stroup, Cynthia, de Bear, Olivia, Dalton, Liam, Rolston, Aimee, McCool, Kevin, Reynolds, R. Kevin, McLean, Karen, Siedel, Jean H., Uppal, Shitanshu

“…To evaluate the impact a tailored opioid prescription calculator has on meeting individual patient opioid needs while avoiding opioid over prescriptions. Our…”
Get full text

Avoidable admissions after minimally invasive hysterectomy by Manorot, Amanda, Uppal, Shitanshu, de Bear, Olivia, Stroup, Cynthia, Dalton, Liam, Rolston, Aimee, McCool, Kevin, Reynolds, R Kevin, McLean, Karen, Siedel, Jean, Straubhar, Alli M

“…To determine the rate of avoidable admissions following anticipated same-day discharge for patients undergoing minimally invasive hysterectomy and to identify…”
Get more information

A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative by Straubhar, Alli M., Filippova, Olga T., Cowan, Renee A., Lakhman, Yulia, Sarasohn, Debra M., Nikolovski, Ines, Torrisi, Jean M., Ma, Weining, Abu-Rustum, Nadeem R., Gardner, Ginger J., Sonoda, Yukio, Zivanovic, Oliver, Chi, Dennis S., Long Roche, Kara

“…To describe outcomes using a multimodal algorithm to triage patients with advanced epithelial ovarian cancer (EOC) to primary debulking surgery (PDS) versus…”
Get full text

Optimization of postoperative opioid prescriptions in gynecologic oncology: Striking a balance between opioid reduction and pain control by Straubhar, Alli M., Dalton, Liam, Rolston, Aimee, McCool, Kevin, De Bear, Olivia, Stroup, Cynthia, Reynolds, R. Kevin, McLean, Karen, Siedel, Jean H., Uppal, Shitanshu

“…To implement a quality-improvement initiative to assess the impact various patient and procedural factors have on postoperative opioid use. To develop a…”
Get full text

Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors by Kahn, Ryan, Filippova, Olga, Gordhandas, Sushmita, An, Anjile, Straubhar, Alli M., Zivanovic, Oliver, Gardner, Ginger J., O'Cearbhaill, Roisin E., Tew, William P., Grisham, Rachel N., Sonoda, Yukio, Long Roche, Kara, Abu-Rustum, Nadeem R., Chi, Dennis S.

“…We assessed a conditional probability of survival (CPS) model to determine the probability of living 10 years after ovarian cancer diagnosis after having…”
Get full text

Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort by Straubhar, Alli M., Chi, Andrew J., Zhou, Qin C., Iasonos, Alexia, Filippova, Olga T., Leitao, Mario M., Awowole, Ibraheem O., Abu-Rustum, Nadeem R., Broach, Vance A., Jewell, Elizabeth L., Sandhu, Jaspreet S., Sonoda, Yukio

“…To explore pre-operative factors and their impact on overall survival (OS) in a modern cohort of patients who underwent pelvic exenteration (PE) for…”
Get full text

Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers by Ehmann, Sarah, Sassine, Dib, Straubhar, Alli M, Praiss, Aaron M, Aghajanian, Carol, Alektiar, Kaled M, Broach, Vance, Cadoo, Karen A, Jewell, Elizabeth L, Boroujeni, Amir Momeni, Kyi, Chrisann, Leitao, Mario M, Mueller, Jennifer J, Murali, Rajmohan, Bhaloo, Shirin Issa, O'Cearbhaill, Roisin E, Park, Kay J, Sonoda, Yukio, Weigelt, Britta, Zamarin, Dmitriy, Abu-Rustum, Nadeem, Friedman, Claire F

“…Gastric-type endocervical adenocarcinoma (GEA) is a rare form of cervical cancer not associated with human papilloma virus (HPV) infection. We summarize our…”
Get full text

A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration by Rios-Doria, Eric, Filippova, Olga T., Straubhar, Alli M., Chi, Andrew, Awowole, Ibraheem, Sandhu, Jaspreet, Broach, Vance, Mueller, Jennifer J., Gardner, Ginger J., Jewell, Elizabeth L., Zivanovic, Oliver, Leitao, Mario M., Long Roche, Kara, Abu-Rustum, Nadeem R., Sonoda, Yukio

“…To evaluate postoperative and oncologic outcomes associated with pelvic exenteration for non-ovarian gynecologic malignancies. This was a retrospective review…”
Get full text

Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events by Straubhar, Alli M., Wolf, Jennifer L., Zhou, Ms Qin C., Iasonos, Alexia, Cham, Stephanie, Wright, Jason D., Long Roche, Kara, Chi, Dennis S., Zivanovic, Oliver

“…To independently validate a published risk-calculator for adverse perioperative outcomes in patients with epithelial ovarian cancer undergoing debulking…”
Get full text

Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2 by Stenehjem, David D., Toole, Michael, Merriman, Joseph, Parikh, Kinjal, Daignault, Stephanie, Scarlett, Sarah, Esper, Peg, Skinner, Katherine, Udager, Aaron, Tantravahi, Srinivas Kiran, Gill, David, Straubhar, Alli M., Agarwal, Archana M., Grossmann, Kenneth F., Samlowski, Wolfram E., Redman, Bruce, Agarwal, Neeraj, Alva, Ajjai

“…Purpose In metastatic renal cell carcinoma (mRCC), survival benefit associated with objective response rates of 16–20 % with high-dose interleukin-2 (HDIL-2)…”
Get full text

Correlation of Degree of Hypothyroidism With Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors by Bailey, Erin B, Tantravahi, Srinivas K, Poole, Austin, Agarwal, Archana M, Straubhar, Alli M, Batten, Julia A, Patel, Shiven B, Wells, Chesley E, Stenehjem, David D, Agarwal, Neeraj

“…Micro-Abstract Hypothyroidism frequently occurs in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor…”
Get full text

The Utility of Physical Examination in Ovarian Cancer Recurrence Detection: A Retrospective Analysis Informing Virtual Surveillance Care by Janke, Monica J., Santiago, Sarah, Straubhar, Alli M., Uppal, Shitanshu

“…(Abstracted from Int J Gynecol Cancer 2022;32:913–917) Disease recurrence is commonly seen in ovarian cancer despite optimal treatment, with approximately 80%…”
Get full text

Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer by McLaughlin, Hannah Dysinger, Straubhar, Alli M., Rolston, Aimee, McCool, Kevin, Brackmann, Melissa, Siedel, Jean Hansen, McLean, Karen, Reynolds, R. Kevin, Uppal, Shitanshu

“…5552 Background: The primary objective was to assess the rate of venous thromboembolism (VTE) in patients with ovarian cancer who received neoadjuvant…”
Get full text

Gastric-type adenocarcinoma of the cervix: Genomic drivers and clinical outcomes by Sassine, Dib, Straubhar, Alli M., Aghajanian, Carol, Alektiar, Kaled M., Broach, Vance, Cadoo, Karen Anne, Jewell, Elizabeth Lin, Kyi, Chrisann, Leitao, Mario M., Mueller, Jennifer Jean, Murali, Rajmohan, O'Cearbhaill, Roisin Eilish, Park, Kay J., Sonoda, Yukio, Weigelt, Britta, Zamarin, Dmitriy, Abu-Rustum, Nadeem, Friedman, Claire Frances

“…Abstract only 6030 Background: Cervical Gastric-type adenocarcinoma (CGA) is a non-HPV-associated adenocarcinoma, comprising 10% of all cervical…”
Get full text

Correlation of IMP3 expression and survival in metastatic renal cell carcinoma with sarcomatoid features (SmRCC) by Tantravahi, Srinivas Kiran, Albertson, Dan, Agarwal, Archana M., Straubhar, Alli M., Poole, Austin, Stenehjem, David D., Liu, Ting, Agarwal, Neeraj

“…Abstract only…”
Get full text